Meta Pixel
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

News and Announcements

Universal Biosenors Acquires Hemostasis Reference Laboratory

  • Published December 19, 2016 12:57PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

19th December 2016 – ASX Announcement

Universal Biosensors Inc (ASX: UBI) has announced that its wholly-owned Canadian operating subsidiary has signed an agreement with LifeLabs LP (LifeLabs) to acquire the assets of LifeLabs’ Hemostasis Reference Laboratory business (HRL) in preparation for future increased production requirements of Siemens’ Xprecia Stride™ test strips.

The HRL business has provided high-quality coagulation testing and calibration services to international customers for more than 20 years, including 5 years of services for UBI. HRL has one of the most diverse offerings of specialised coagulation services in the world.

To view the full announcement please click on the button below.

Capital Insights
Cosmo Innovations Founder Eyes Global Rollout of SkinGate, IPO by 2027

Dr. Mathew Jafarzadeh, founder of Cosmo Innovations, is set to revolutionize the $65 billion home beauty tech market with SkinGate, a patented skincare infusion device. Following his presentation at Emergence 2025, he revealed plans for a global rollout, aiming for a 2027 IPO on NASDAQ or the Hong Kong Exchange. Discover how SkinGate, backed by 110+ patents, seeks to attract “smart capital” and redefine skincare delivery.

Company Updates
Stop Leaving Millions on the Table: The Investor Secret You’re Missing!

In an Australian business landscape increasingly defined by volatility and intense competition for capital, the art of robust stakeholder relations has evolved beyond a mere governance checkbox. For founders, boards, and executive teams, the ability to genuinely inform and engage investors isn’t just about meeting disclosure requirements; it’s a strategic imperative that directly impacts capital […]

Capital Insights
Ecosystems Over Exit: Callum Laing on Disrupting Small Business M&A

At Emergence Singapore, Callum Laing of Veblen Director Program presented a bold new vision for small business M&A: “Ecosystems Over Exit.” He shared how his Unity Group takes cash-generating businesses public, focusing on growth over immediate founder exit. Discover his unique approach, how interconnected ecosystems drive massive deal flow, and a three-step framework for any business to amplify reach and capital raising.

Join over 45,000+ sophisticated investors

Join Now